Role of the Heterocycles to Design Anti-Cancer Agents

Anticancer Agents Med Chem. 2022;22(19):3194-3195. doi: 10.2174/187152062219220930154651.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Drug Design
  • Heterocyclic Compounds* / pharmacology
  • Heterocyclic Compounds* / therapeutic use
  • Humans

Substances

  • Antineoplastic Agents
  • Heterocyclic Compounds